HCW Biologics logo
HCW Biologics
HCWB | NASDAQ
Chart Builder DCF Calculator
$0.80
+$0.03 (+3.48%)
At close: Nov 16, 2026, 4:00 PM ET
$0.77
-$0.03 (-3.61%)
After-hours: Nov 16, 2026, 6:56 PM ET

HCW Biologics Company Profile

Company profile explained

Company Profile

HCW Biologics Inc. operates as a preclinical-stage biopharmaceutical firm, primarily engaged in the discovery and advancement of novel immunotherapies. Its research and development efforts are focused on addressing chronic, low-grade inflammation and a spectrum of age-related diseases. The company's leading therapeutic candidates include HCW9218, an injectable immunotherapeutic designed for patients with a variety of cancers, such as pancreatic, ovarian, breast, prostate, and colorectal, as well as for pulmonary fibrosis. Another key product, HCW9302, targets autoimmune conditions like alopecia areata and various metabolic disorders. Beyond these, HCW Biologics is also developing HCW9201, a cell-based therapy currently in Phase II clinical trials for the treatment of relapsed/refractory acute myeloid leukemia. Additionally, HCW9206 is under development specifically for acute myeloid leukemia. Incorporated in 2018, the company's corporate headquarters are situated in Miramar, Florida.

Key Executives

Name Position
Hing C. Wong Founder, Chief Executive Officer, Director & Secretary
Rebecca Byam Chief Financial Officer
Lee D. Flowers Senior Vice President of Business Development
Nicole Valdivieso Vice President of Legal Affairs
Peter Rhode Chief Scientific Officer & Vice President of Clinical Operations

Latest SEC Filings

Date Type Title
Oct 09, 2026 EFFECT Filing
Oct 08, 2026 D Filing
Oct 02, 2026 S-1 Filing
Oct 01, 2026 DEF 14A Filing
Sep 24, 2026 8-K Current Report
Sep 10, 2026 8-K Current Report
Sep 09, 2026 PRER14A Filing
Sep 08, 2026 8-K Current Report
Sep 08, 2026 PRE 14A Filing
Aug 31, 2026 EFFECT Filing
View All SEC Filings ➞
HCW Biologics
HCW Biologics logo
Country United States
IPO Date Jul 20, 2021
Industry Biotechnology
Sector Healthcare
Employees 35
CEO Hing C. Wong

Contact Details

2929 North Commerce Parkway Miramar, Florida 33025 United States

Stock Details

Ticker Symbol HCWB
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001828673
CUSIP Number 40423R303
ISIN Number US40423R3030
SIC Code 2834

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.